ZYMAR^® is the first fourth-generation, topical fluoroquinolone indicated for the treatment of bacterial conjunctivitis approved by the U.S. Food and Drug Administration (FDA). The FDA approved ZYMAR^® in 2003 for the treatment of bacterial conjunctivitis caused by susceptible strains of Corynebacterium propinquum,*Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis,*Streptococcus pneumoniae, and Haemophilus influenzae. (*Efficacy for this organism was studied in fewer than 10 infections.)

ZYMAR^® ophthalmic solution provides rapid and effective protection from many bacteria that causes bacterial conjunctivitis. In fact, ZYMAR^® has been shown to quickly eradicate common pathogens in vitro (clinical significance unknown). Additionally, it is well-tolerated by patients and can be used in children as young as one year.

Uses
Bimat are eye drops given to alleviate intraocular pressure in patients diagnosed with glaucoma. By alleviating the pressure the risks of blindness associated with this condition are significantly reduced.

In addition to aiding patients suffering from glaucoma, Bimat Eye Drops can also be useful for those with hypotrichosis of the eyelashes as when applied to eye lashes it can encourage growth and thickening.

Dosage and administration
If you wear contact lenses always remove them before applying the eye drops.

To apply, hold your eye open and carefully squeeze a few drops into your eye. As soon as you have done this slowly close and reopen you eyes to help spread the liquid over the eye.

In order to apply the eye drops to your eye lashes you will need to purchase additional applicators from a pharmacy. To apply, squeeze a one drop of the solution onto the applicator's tip, then run the applicator along your eyelash. Each applicator should be used for one eyelash only and immediately thrown away after use to avoid contamination.